Radium-223 is a radiopharmaceutical drug primarily used in the treatment of which type of cancer?

💡 Explanation:

Radium-223 (marketed as Xofigo) is an alpha-emitting radiopharmaceutical specifically used to treat metastatic castration-resistant prostate cancer (mCRPC) that involves symptomatic bone metastases.